The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Bristol-Myers Squibb; Novartis; Pfizer
Speakers' Bureau - Merck; Pfizer
Outcomes of anti-PD-1 therapy in mesothelioma and correlation with PD-L1 expression.
 
Gareth Rivalland
Honoraria - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Steven Chuan-Hao Kao
Honoraria - AstraZeneca; Bristol-Myers Squibb; Roche
Research Funding - Merck Sharp & Dohme
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb
 
Nick Pavlakis
Honoraria - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Merck Serono; Novartis; Pfizer; Roche; Sanofi; Specialised Therapeutics
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Merck Serono; Novartis; Pfizer; Roche; Specialised Therapeutics
 
Brett Gordon Maxwell Hughes
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Bibhusal Thapa
No Relationships to Disclose
 
Abhijit Pal
No Relationships to Disclose
 
Marzena Walkiewicz
No Relationships to Disclose
 
Allan Solomon Zimet
No Relationships to Disclose
 
Shane White
No Relationships to Disclose
 
Ken O'Byrne
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche
Patents, Royalties, Other Intellectual Property - Queensland University of Technology
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer
 
Paul Mitchell
Honoraria - Merck Sharp & Dohme; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Merck Sharp & Dohme; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb
 
Thomas John
No Relationships to Disclose